Cellebrite DI Ltd.

NasdaqGS:CLBT Stock Report

Market Cap: US$5.2b

Cellebrite DI Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Tom Hogan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

A Look At The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

Jan 10
A Look At The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

Cellebrite: There Are Potential Risks That Could Damper Growth

Nov 08

Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

Oct 30
Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?

There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Sep 10
There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased

Cellebrite: Rating Downgrade As Valuation Has Caught Up

Aug 27

Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Aug 17
Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up

Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Jun 25
Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

May 21
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?

Cellebrite: Big Fish In A Small Pond

Apr 29

Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Mar 14
Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

CEO

Tom Hogan (65 yo)

less than a year

Tenure

Mr. Thomas E. Hogan, also known as Tom, had been Executive Chairman of Cellebrite DI Ltd. since August 2023 until January 1, 2025 and serves as its Interim Chief Executive Officer since January 1, 2025. He...

Leadership Team

NamePositionTenureCompensationOwnership
Yossi Carmil
Founderno dataUS$2.15m2.26%
$ 118.3m
Dana Gerner
Chief Financial Officer10.7yrsUS$1.19mno data
Ronnen Armon
Chief Products & Technologies Officer4.5yrsUS$1.03mno data
Leeor Ben-Peretz
Chief Strategy Officer7.9yrsUS$895.00kno data
Thomas Hogan
Interim CEOless than a yearno datano data
Andrew Kramer
Vice President of Investor Relationsno datano datano data
Ayala Shapira
General Counsel & Chief Compliance Officer2.3yrsno datano data
David Gee
Chief Marketing Officerless than a yearno datano data
Zohar Tadmor-Eilat
Chief People Officer2yrsno datano data
Marcus Jewell
Global Chief Revenue Officer1.2yrsno datano data

2.2yrs

Average Tenure

56yo

Average Age

Experienced Management: CLBT's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Thomas Hogan
Interim CEO1.4yrsno datano data
Michael Capellas
Lead Independent Directorno datano datano data
Dafna Gruber
Independent External Director3.4yrsno datano data
Adam Clammer
Independent Chairman3.4yrsno data0.37%
$ 19.2m
Mark Ferrer
Independent Directorless than a yearno datano data
Brandon Van Buren
Independent Director1.7yrsno datano data
Elly Keinan
Independent Director4.3yrsno datano data
Nadine Baudot-Trajtenberg
Independent External Director3.4yrsno datano data
Yonatan Domnitz
Independent Director4.8yrsno datano data
Ryusuke Utsumi
Independent Director4.8yrsno datano data
Koby Huberman
Advisory Board Memberno datano datano data
Barbara Grewe
Independent Directorless than a yearno datano data

3.4yrs

Average Tenure

59yo

Average Age

Experienced Board: CLBT's board of directors are considered experienced (3.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 00:59
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cellebrite DI Ltd. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tal LianiBofA Global Research
Tomer ZilbermanBofA Global Research
Tyler RadkeCitigroup Inc